| 5.35 -0.15 (-2.73%) | 10-07 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term | |
|||
| Targets | 6-month : | 6.85 | 1-year : | 7.33 |
| Resists | First : | 5.87 | Second : | 6.28 |
| Pivot price | 5.65 |
|||
| Supports | First : | 5.21 | Second : | 4.33 |
| MAs | MA(5) : | 5.42 |
MA(20) : | 5.67 |
| MA(100) : | 5.92 |
MA(250) : | 5.24 | |
| MACD | MACD : | -0.2 |
Signal : | -0.2 |
| %K %D | K(14,3) : | 23.2 |
D(3) : | 20.6 |
| RSI | RSI(14): 39.6 |
|||
| 52-week | High : | 9.35 | Low : | 2.83 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.[ ACB ] has closed above bottom band by 10.1%. Bollinger Bands are 47.7% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 15 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 5.65 - 5.67 | 5.67 - 5.69 |
| Low: | 5.39 - 5.41 | 5.41 - 5.44 |
| Close: | 5.46 - 5.49 | 5.49 - 5.54 |
Aurora Cannabis Inc. produces, distributes, and sells cannabis and cannabis derivative products in Canada and internationally. It also engages in facility engineering and design, cannabis breeding, research, production, derivatives, product development, wholesale, and retail distribution activities. The company produces various strains of dried cannabis, cannabis oil and capsules, and topical kits for medical patients. It also sells vaporizers; consumable vaporizer accessories; and herb mills for using CanniMed herbal cannabis products, as well as grinders and vaporizer lockable containers. In addition, the company engages in the development of medical cannabis products at various stages of development, including oral, topical, edible, and inhalable products; and operation of CanvasRX, a network of cannabis counseling and outreach centers. Further, it provides patient counselling services; design and construction services; and cannabis analytical product testing services. The company's brand portfolio includes Aurora, Aurora Drift, San Rafael '71, Daily Special, AltaVie, MedReleaf, CanniMed, Whistler, Woodstock, and WMMC. Aurora Cannabis Inc. is headquartered in Edmonton, Canada.
Thu, 03 Oct 2024
ACB Stock Likely to Gain From Genome BC-Funded Aroma Research Project - Yahoo Finance
Wed, 02 Oct 2024
Aurora Cannabis Announces Collaboration on Genome BC-Funded Project Addressing Distinct Cannabis Aromas - StockTitan
Wed, 02 Oct 2024
Aurora Cannabis Announces Collaboration on Genome BC-Funded Project Addressing Distinct Cannabis Aromas - PR Newswire
Tue, 01 Oct 2024
Aurora Cannabis Inc. stock falls Tuesday, underperforms market - MarketWatch
Fri, 27 Sep 2024
Aurora Cannabis Inc. stock rises Friday, outperforms market - MarketWatch
Mon, 12 Aug 2024
Aurora Cannabis Announces Results of 2024 Annual General and Special Meeting - PR Newswire
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Drug Manufacturers - Specialty & Generic
|
|
| Shares Out | 55 (M) |
| Shares Float | 54 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 13.3 (%) |
| Shares Short | 2,730 (K) |
| Shares Short P.Month | 2,320 (K) |
| EPS | -0.47 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 10.27 |
| Profit Margin | -11.6 % |
| Operating Margin | 2.2 % |
| Return on Assets (ttm) | -1.9 % |
| Return on Equity (ttm) | -6.2 % |
| Qtrly Rev. Growth | 11.6 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 5.1 |
| EBITDA (p.s.) | 0.06 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -49 (M) |
| Levered Free Cash Flow | -106 (M) |
| PE Ratio | -11.39 |
| PEG Ratio | 0 |
| Price to Book value | 0.52 |
| Price to Sales | 1.04 |
| Price to Cash Flow | -5.99 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|